 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Oct 12, 2023 |
| Title |
Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
37548590 |
| |
| Submission date |
Nov 14, 2022 |
| Last update date |
Jan 10, 2024 |
| Contact name |
Mark Dawson |
| E-mail(s) |
mark.dawson@petermac.org
|
| Organization name |
Peter MacCallum Cancer Centre
|
| Department |
Cancer Research
|
| Street address |
305 Grattan Street
|
| City |
Melbourne |
| ZIP/Postal code |
3000 |
| Country |
Australia |
| |
|
| Platforms (3) |
|
| Samples (35)
|
| GSM6729976 |
AT3, STM2457, 24h, rep1 |
| GSM6729977 |
AT3, STM2457, 24h, rep2 |
| GSM6729978 |
AT3, STM2457, 24h, rep3 |
| GSM6729979 |
AT3, STM3006, 24h, rep1 |
| GSM6729980 |
AT3, STM3006, 24h, rep2 |
| GSM6729981 |
AT3, STM3006, 24h, rep3 |
| GSM6729982 |
AT3, DMSO, 48h, rep1 |
| GSM6729983 |
AT3, DMSO, 48h, rep2 |
| GSM6729984 |
AT3, DMSO, 48h, rep3 |
| GSM6729985 |
AT3, STM2457, 48h, rep1 |
| GSM6729986 |
AT3, STM2457, 48h, rep2 |
| GSM6729987 |
AT3, STM2457, 48h, rep3 |
| GSM6729988 |
AT3, STM3006, 48h, rep1 |
| GSM6729989 |
AT3, STM3006, 48h, rep2 |
| GSM6729990 |
AT3, STM3006, 48h, rep3 |
| GSM7879966 |
B16 cas9 cells, co-cultured with OT-I cells 1:1 (E:T), 20 μmol/L Mettl3i |
| GSM7879967 |
B16 cas9 cells, co-cultured with OT-I cells 1:1 (E:T), DMSO |
| GSM7879968 |
B16 cas9 cells, co-cultured with OT-I cells 1:20 (E:T), 20 μmol/L Mettl3i |
| GSM7879969 |
B16 cas9 cells, co-cultured with OT-I cells 1:20 (E:T), DMSO |
| GSM7879970 |
B16 cas9 cells, co-cultured with OT-I cells 1:5 (E:T), 20 μmol/L Mettl3i |
| GSM7879971 |
B16 cas9 cells, co-cultured with OT-I cells 1:5 (E:T), 5 μmol/L Mettl3i |
| GSM7879972 |
B16 cas9 cells, co-cultured with OT-I cells 1:5 (E:T), DMSO |
| GSM7879973 |
B16 cas9 cells, 20 μmol/L Mettl3i |
| GSM7879974 |
B16 cas9 cells, 5 μmol/L Mettl3i |
| GSM7879975 |
B16 cas9 cells, DMSO |
| GSM7879976 |
B16 cas9 cells, early time point |
| GSM8002873 |
STM3006_1 |
| GSM8002874 |
STM2457_2 |
| GSM8002875 |
STM3006_2 |
| GSM8002876 |
DMSO_1 |
| GSM8002877 |
STM2457_1 |
| GSM8002878 |
DMSO_2 |
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE217920 |
Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity [RNA-seq] |
| GSE246837 |
Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances anti-tumour immunity [CRISPR screen] |
| GSE252537 |
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity [ONT direct RNA-seq] |
| GSE252960 |
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity [QuantSeq 3’ mRNA-Seq] |
|
| Relations |
| BioProject |
PRJNA901397 |
|
|
|
|
 |
Less...
More...